Release Details

SAN DIEGO, Nov 15, 2004 /PRNewswire-FirstCall via COMTEX/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will present at SG Cowen & Company's 5th Annual Global Health Care Conference at The Hilton Geneva, Switzerland tomorrow, Tuesday, November 16, 2004 at 8:35AM Central European Time (CET)/Monday, Nov. 15, 2004 at 11:35PM Pacific Standard Time (PST). The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.

Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences will highlight indiplon, the Company's recently submitted New Drug Application to the U.S. Food and Drug Administration (FDA) for the treatment of insomnia, as well as provide an update on the Company's diverse research and development programs.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or Elizabeth Foster. A replay will be available approximately one hour after the presentation concludes and will be archived until Wednesday, December 1, 2004.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.

SOURCE Neurocrine Biosciences, Inc.

Claudia Jones, or Elizabeth Foster, both of Neurocrine
Biosciences, +1-858-617-7600

http://www.neurocrine.com